Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) is a novel coronavirus that causes a highly contagious respiratory disease, SARS, with significant mortality. Although factors contributing to the highly pathogenic nature of SARS-CoV remain poorly understood, it has been reported that SARS-CoV infection does not induce type I interferons (IFNs) in cell culture. However, it is uncertain whether SARS-CoV evades host detection or has evolved mechanisms to counteract innate host defenses. We show here that infection of SARS-CoV triggers a weak IFN response in cultured human lung/bronchial epithelial cells without inducing the phosphorylation of IFN-regulatory factor 3 (IRF-3), a latent cellular transcription factor that is pivotal for type I IFN synthesis. Furthermore, SARS-CoV infection blocked the induction of IFN antiviral activity and the up-regulation of protein expression of a subset of IFN-stimulated genes triggered by double-stranded RNA or an unrelated paramyxovirus. In searching for a SARS-CoV protein capable of counteracting innate immunity, we identified the papain-like protease (PLpro) domain as a potent IFN antagonist. The inhibition of the IFN response does not require the protease activity of PLpro. Rather, PLpro interacts with IRF-3 and inhibits the phosphorylation and nuclear translocation of IRF-3, thereby disrupting the activation of type I IFN responses through either Toll-like receptor 3 or retinoic acid-inducible gene I/melanoma differentiation-associated gene 5 pathways. Our data suggest that regulation of IRF-3-dependent innate antiviral defenses by PLpro may contribute to the establishment of SARS-CoV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“(ii) the papain‐like protease domain of CoV‐NL63 binds BECN1 and STING1, thus hindering BECN1‐mediated autophagosome formation and inhibiting IFN production (Devaraj et al, 2007; Chen et al, 2014)”
From Autophagy in major human diseases (2021) · cites this paper as Devaraj et al, 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
Self-citationIKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,474
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S. N., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,026
Innate immune recognition of viral infection
Kawai, T., & Akira, S. (2006) · Nature Immunology · doi:10.1038/ni1303 · Cited by 1,899
VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling
Xu, L.-G., Wang, Y.-Y., Han, K.-J., Li, L.-Y., Zhai, Z., & Shu, H.-B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.014 · Cited by 1,853
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G.-P., Lin, R., & Hiscott, J. (2003) · Science · doi:10.1126/science.1081315 · Cited by 1,661
Self-citationYamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6668 · Cited by 1,227
Type I Interferons in Host Defense
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.007 · Cited by 1,195
Ubiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
Self-citationAn efficient one-step site-directed and site-saturation mutagenesis protocol
Zheng, L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh110 · Cited by 1,178
Severe acute respiratory syndrome
Peiris, J. S. M., Guan, Y., & Yuen, K. Y. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,139
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
Self-citationSen, G. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.255 · Cited by 968
Lin, R., Heylbroeck, C., Pitha, P. M., & Hiscott, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2986 · Cited by 915
Self-citationType 1 Interferons and the Virus-Host Relationship: A Lesson in Détente
García-Sastre, A., & Biron, C. A. (2006) · Science · doi:10.1126/science.1125676 · Cited by 885
Yoneyama, M., Suhara, W., Fukuhara, Y., Fukuda, M., Nishida, E., & Fujita, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.1087 · Cited by 841
Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease
Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S. M., & Gale, M. (2003) · Science · doi:10.1126/science.1082604 · Cited by 788
Self-citationKopecky-Bromberg, S. A., Martínez-Sobrido, L., Frieman, M., Baric, R. A., & Palese, P. (2007) · Journal of Virology · doi:10.1128/jvi.01782-06 · Cited by 673
Barretto, N., Jukneliene, D., Ratia, K., Chen, Z., Mesecar, A. D., & Baker, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15189-15198.2005 · Cited by 582
Self-citationUBP43 (USP18) Specifically Removes ISG15 from Conjugated Proteins
Malakhov, M. P., Malakhova, O. A., Kim, K. I., Ritchie, K. J., & Zhang, D.-E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109078200 · Cited by 531
NF-κB, chemokine gene transcription and tumour growth
Richmond, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri887 · Cited by 523
Grandvaux, N., Servant, M. J., tenOever, B., Sen, G. C., Balachandran, S., Barber, G. N., Lin, R., & Hiscott, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5532-5539.2002 · Cited by 519
Self-citationSnijder, E. J., van der Meer, Y., Zevenhoven-Dobbe, J., Onderwater, J. J. M., van der Meulen, J., Koerten, H. K., & Mommaas, A. M. (2006) · Journal of Virology · doi:10.1128/jvi.02501-05 · Cited by 512
Antiviral innate immunity pathways
Seth, R. B., Sun, L., & Chen, Z. J. (2006) · Cell Research · doi:10.1038/sj.cr.7310019 · Cited by 494
Self-citationHarcourt, B. H., Jukneliene, D., Kanjanahaluethai, A., Bechill, J., Severson, K. M., Smith, C. M., Rota, P. A., & Baker, S. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13600-13612.2004 · Cited by 462
Self-citationKrikos, A., Laherty, C. D., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37138-8 · Cited by 444
Emeny, J. M., & Morgan, M. J. (1979) · Journal of General Virology · doi:10.1099/0022-1317-43-1-247 · Cited by 440
RNA Replication of Mouse Hepatitis Virus Takes Place at Double-Membrane Vesicles
Gosert, R., Kanjanahaluethai, A., Egger, D., Bienz, K., & Baker, S. C. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3697-3708.2002 · Cited by 432
Self-citationKamitani, W., Narayanan, K., Huang, C., Lokugamage, K., Ikegami, T., Ito, N., Kubo, H., & Makino, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603144103 · Cited by 416
Ratia, K., Saikatendu, K. S., Santarsiero, B. D., Barretto, N., Baker, S. C., Stevens, R. C., & Mesecar, A. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510851103 · Cited by 414
Self-citationUltrastructural Characterization of SARS Coronavirus
Goldsmith, C. S., Tatti, K. M., Ksiazek, T. G., Rollin, P. E., Comer, J. A., Lee, W. W., Rota, P. A., Bankamp, B., Bellini, W. J., & Zaki, S. R. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030913 · Cited by 405
Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon
Cervantes-Barragan, L., Züst, R., Weber, F., Spiegel, M., Lang, K. S., Akira, S., Thiel, V., & Ludewig, B. (2007) · Blood · doi:10.1182/blood-2006-05-023770 · Cited by 397
Ziebuhr, J. (2005) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26765-4_3 · Cited by 393
The intracellular sites of early replication and budding of SARS-coronavirus
Stertz, S., Reichelt, M., Spiegel, M., Kuri, T., Martínez-Sobrido, L., García-Sastre, A., Weber, F., & Kochs, G. (2007) · Virology · doi:10.1016/j.virol.2006.11.027 · Cited by 382
Toll-Like Receptors and RNA Helicases: Two Parallel Ways to Trigger Antiviral Responses
Meylan, E., & Tschopp, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.012 · Cited by 372
Lindner, H. A., Fotouhi-Ardakani, N., Lytvyn, V., Lachance, P., Sulea, T., & Ménard, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15199-15208.2005 · Cited by 371
Li, K., Chen, Z., Kato, N., Gale, M., & Lemon, S. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414139200 · Cited by 367
Self-citationWeaver, B. K., Kumar, K. P., & Reich, N. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1359 · Cited by 352
Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor
Yang, Y., Liang, Y., Qu, L., Chen, Z., Yi, M., Li, K., & Lemon, S. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611506104 · Cited by 320
Self-citationThe NS1 Gene Contributes to the Virulence of H5N1 Avian Influenza Viruses
Li, Z., Jiang, Y., Jiao, P., Wang, A., Zhao, F., Tian, G., Wang, X., Yu, K., Bu, Z., & Chen, H. (2006) · Journal of Virology · doi:10.1128/jvi.00993-06 · Cited by 315
Spiegel, M., Pichlmair, A., Martínez-Sobrido, L., Cros, J., García-Sastre, A., Haller, O., & Weber, F. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2079-2086.2005 · Cited by 279
Iwamura, T., Yoneyama, M., Yamaguchi, K., Suhara, W., Mori, W., Shiota, K., Okabe, Y., Namiki, H., & Fujita, T. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00426.x · Cited by 263
Transcriptional signaling by double-stranded RNA: role of TLR3
SEN, G., & SARKAR, S. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.006 · Cited by 258
Immunity by ubiquitylation: a reversible process of modification
Liu, Y.-C., Penninger, J., & Karin, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1731 · Cited by 257
Yount, B., Roberts, R. S., Sims, A. C., Deming, D., Frieman, M. B., Sparks, J., Denison, M. R., Davis, N., & Baric, R. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14909-14922.2005 · Cited by 253
Solórzano, A., Webby, R. J., Lager, K. M., Janke, B. H., García-Sastre, A., & Richt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7535-7543.2005 · Cited by 252
Attenuation of Equine Influenza Viruses through Truncations of the NS1 Protein
Quinlivan, M., Zamarin, D., García-Sastre, A., Cullinane, A., Chambers, T., & Palese, P. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8431-8439.2005 · Cited by 241
Servant, M. J., Grandvaux, N., tenOever, B. R., Duguay, D., Lin, R., & Hiscott, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209851200 · Cited by 216
Self-citationLin, R., Yang, L., Nakhaei, P., Sun, Q., Sharif-Askari, E., Julkunen, I., & Hiscott, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510326200 · Cited by 215
Self-citationInnate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication
Collins, S. E., Noyce, R. S., & Mossman, K. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1706-1717.2004 · Cited by 198
Akazawa, T., Ebihara, T., Okuno, M., Okuda, Y., Shingai, M., Tsujimura, K., Takahashi, T., Ikawa, M., Okabe, M., Inoue, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605978104 · Cited by 188
Eickelberg, O., Pansky, A., Mussmann, R., Bihl, M., Tamm, M., Hildebrand, P., Perruchoud, A. P., & Roth, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12933 · Cited by 185
Peters, K. L., Smith, H. L., Stark, G. R., & Sen, G. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092133199 · Cited by 158
Review: Control of IRF-3 Activation by Phosphorylation
Yoneyama, M., Suhara, W., & Fujita, T. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452674 · Cited by 158
Tseng, C.-T. K., Tseng, J., Perrone, L., Worthy, M., Popov, V., & Peters, C. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9470-9479.2005 · Cited by 143
Self-citationMossel, E. C., Huang, C., Narayanan, K., Makino, S., Tesh, R. B., & Peters, C. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3846-3850.2005 · Cited by 142
Self-citationVersteeg, G. A., Bredenbeek, P. J., van den Worm, S. H. E., & Spaan, W. J. M. (2007) · Virology · doi:10.1016/j.virol.2007.01.020 · Cited by 140
GB Virus B Disrupts RIG-I Signaling by NS3/4A-Mediated Cleavage of the Adaptor Protein MAVS
Chen, Z., Benureau, Y., Rijnbrand, R., Yi, J., Wang, T., Warter, L., Lanford, R. E., Weinman, S. A., Lemon, S. M., Martin, A., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02076-06 · Cited by 136
Self-citationEhrhardt, C., Kardinal, C., Wurzer, W. J., Wolff, T., von Eichel‐Streiber, C., Pleschka, S., Planz, O., & Ludwig, S. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.069 · Cited by 130
Chen, Z., Rijnbrand, R. C. A., Jangra, R. K., Devaraj, S. G., Qu, L., Ma, Y., Lemon, S. M., & Li, K. (2007) · Virology · doi:10.1016/j.virol.2007.04.023 · Cited by 129
Self-citationp38-dependent Activation of Interferon Regulatory Factor 3 by Lipopolysaccharide
Navarro, L., & David, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35535 · Cited by 123
Langford, M. P., Weigent, D. A., Stanton, G. J., & Baron, S. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(81)78139-4 · Cited by 114
Zhou, H., & Perlman, S. (2007) · Journal of Virology · doi:10.1128/jvi.01512-06 · Cited by 114
Li, K., Prow, T. W., Lemon, S. M., & Beard, M. R. (2002) · Hepatology · doi:10.1053/jhep.2002.32968 · Cited by 97
Self-citationRonni, T., Matikainen, S., Lehtonen, A., Palvimo, J. J., DELLIS, J., Eylen, F. V., Goetschy, J., Horisberger, M. A., Content, J., & Julkunen, I. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.773 · Cited by 91
Fries, K., Miller, W. E., & Raab‐Traub, N. (1999) · Virology · doi:10.1006/viro.1999.9980 · Cited by 50
The Coronavirus Replicase: Insights into a Sophisticated Enzyme Machinery
Ziebuhr, J. (2006) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-33012-9_1 · Cited by 27
McKimm‐Breschkin, J. L., & Holmes, I. H. (1982) · Infection and Immunity · doi:10.1128/iai.36.3.857-863.1982 · Cited by 27
Pin-ning down immune responses to RNA viruses
Goutagny, N., Severa, M., & Fitzgerald, K. A. (2006) · Nature Immunology · doi:10.1038/ni0606-555 · Cited by 13
Cited by
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
“SARS-CoV PLpro disrupts NF-κB signalling 73 and blocks the phosphorylation of IRF3 indirectly 73,74 .”
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
“Other proteins, including SARS-CoV-1 PLP, N, ORF3b and ORF6, block IRF3 phosphorylation and nuclear translocation (Devaraj et al., 2007; .”
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Harrison, A. G., Lin, T., & Wang, P. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.004 · Cited by 1,186
Metadata
- Authors
- Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., & Li, K.
- Affiliations
- The University of Texas Medical Branch at Galveston (US)
- Loyola University Chicago (US)
- Lady Davis Institute for Medical Research (CA)
- Corresponding author
- Li, Kui
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 282
- Issue
- 44
- Pages
- 32208-32221
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2756044
- OpenAlex
- W190626844
- Cited by
- 411
- References
- 80
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 14 · 2023: 17 · 2022: 37 · 2021: 72 · 2020: 71 · 2019: 9 · 2018: 5 · 2017: 14 · 2016: 9 · 2015: 9 · 2014: 30 · 2013: 18 · 2012: 13
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4687 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01ai30039-19-0-2)
- National Institute on Drug Abuse (DA-018054, R21DA018054)
- National Institute of Allergy and Infectious Diseases (P01AI060915, AI060915, AI30039, AI-069285, AI 45798, AI057156, N01-AI-030039, U54AI057156, R01AI069285, R01AI045798)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- SARS-CoV, IRF3, papain-like protease, type I interferon, innate immune evasion, interferon antagonism, IRF3 phosphorylation, TLR3, IFN-stimulated genes, lung epithelial cells, viral pathogenesis
- MeSH terms
- Animals, Bronchi, Cell Line, Humans, Immunity, Innate, Interferon Type I, Peptide Hydrolases, Viral Proteins, Protein Structure, Tertiary, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, Interferon Regulatory Factor-3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.